Similar articles

• Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.

  Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB. Zhang YJ, et al. Biochem Biophys Res Commun. 1993 Oct 29;196(2):1010-6. doi: 10.1006/bbrc.1993.2350. Biochem Biophys Res Commun. 1993. PMID: 8240318
• [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].

  Peng SH, Yang JF, Xie PP, Deng H, Li H, Feng DY. Peng SH, et al. Ai Zheng. 2005 Jun;24(6):695-8. Ai Zheng. 2005. PMID: 15946481 Chinese.
• [Inhibitory effect of cyclin D1 antisense cDNA on human hepatocarcinoma cell line HepG2].

  Xiao ZY, Chen XP, Huang ZY. Xiao ZY, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Oct;13(10):768-71. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16248951 Chinese.
• [Tumor suppressor RB gene and its related molecules in hepatocellular carcinoma].

  Nishida N, Fukuda Y. Nishida N, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:134-7. Nihon Rinsho. 2001. PMID: 11761929 Review. Japanese. No abstract available.
• Alteration of cell cycle-related genes in hepatocarcinogenesis.

  Nishida N, Fukuda Y, Ishizaki K, Nakao K. Nishida N, et al. Histol Histopathol. 1997 Oct;12(4):1019-25. Histol Histopathol. 1997. PMID: 9302564 Review.